Published in Medicine and Law Weekly, August 3rd, 2007
Study 1: Scientists discuss in "Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy" new findings in thrombosis. According to a study from Kiel, Germany, "We have shown that the thrombin G-protein coupled receptors (GPCR) designated as protease-activated receptors (PAR-1) are expressed in primary cancer cells isolated from peritoneal and pleural malignant effusions. Here, our main goal was to evaluate several coagulation and thrombin activation effectors and markers in a series of 136 malignant effusions...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly